Skip to main content
. Author manuscript; available in PMC: 2021 Mar 25.
Published in final edited form as: Clin Oncol Case Rep. 2020 Sep 17;3(5):142.

Figure 1:

Figure 1:

CT and MRI scans pre-and post-checkpoint inhibitor therapy; (A) Pretreatment CT chest scan showing a 7.2 cm right axillary metastasis. Decrease in the size of metastases and ongoing response was observed at 1 year (following 12 cycles of therapy) with imaging showing a stable node measuring 3.5 cm (white arrows); (B) Post-SRS and pre-CPI brain MRI scan demonstrating right and left sided supratentorial metastatic lesions on contrast-enhanced MPRAGE imaging and corresponding edema on FLAIR. Post-CPI treatment scan shows no evidence of residual metastasis at 1 year. Arrow head shows resolution of the largest lesion on the left.